The Etiology and management of radiotherapy-induced fatigue

References

• Zagar TM, Willett CG, Czito BG. Intensity-modulated radiation therapy for anal cancer: toxicity versus outcomes. Oncology (Williston Park). 2010;24(9):815–23, 828.
   PubMed Web of Science ®Google Scholar
• Khan HA, Alhomida AS. A review of the logistic role of L-carnitine in the management of radiation toxicity and radiotherapy side effects. J Appl Toxicol. 2011;31(8):707–713. doi:10.1002/jat.1716.
   PubMed Web of Science ®Google Scholar
• Damber J-E, Aus G. Prostate cancer. Lancet. 2008;371(9625):1710–1721. doi:10.1016/S0140-6736(08)60729-1.
   PubMed Web of Science ®Google Scholar
• Berger AM, Mooney K, Alvarez-Perez A, et al. Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw. 2015;13(8):1012–1039.
   PubMed Web of Science ®Google Scholar
• Bower JE. Cancer-related fatigue–mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597–609. doi:10.1038/nrclinonc.2014.127.
   PubMed Web of Science ®Google Scholar
• Stone HB, Coleman CN, Anscher MS, et al. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003;4(9):529–536.
   PubMed Web of Science ®Google Scholar
• Bucci MK, Bevan A, Roach M 3rd. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin. 2005;55(2):117–134.
   PubMed Web of Science ®Google Scholar
• Piper BF, Cella D. Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Canc Netw. 2010;8(8):958–966.
   PubMed Web of Science ®Google Scholar
• Barsevick A, Frost M, Zwinderman A, et al. I’m so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res. 2010;19(10):1419–1427. doi:10.1007/s11136-010-9757-7.
   PubMed Web of Science ®Google Scholar
• Weis J. Cancer-related fatigue: prevalence, assessment and treatment strategies. Expert Rev Pharmacoecon Outcomes Res. 2011;11(4):441–446. doi:10.1586/erp.11.44.
   PubMed Web of Science ®Google Scholar
• Oh HS, Seo WS. Systematic review and meta-analysis of the correlates of cancer-related fatigue. Worldviews Evid Based Nurs. 2011;8(4):191–201. doi:10.1111/j.1741-6787.2011.00214.x.
   PubMed Web of Science ®Google Scholar
• Campos MP, Hassan BJ, Riechelmann R, et al. Cancer-related fatigue: a practical review. Ann Oncol. 2011;22(6):1273–1279. doi:10.1093/annonc/mdq458.
   PubMed Web of Science ®Google Scholar
• Mitchell SA. Cancer-related fatigue: state of the science. PM&R. 2010;2(5):364–383. doi:10.1016/j.pmrj.2010.03.024.
   Web of Science ®Google Scholar
• Holliday EB, Dieckmann NF, McDonald TL, et al. Relationship between fatigue, sleep quality and inflammatory cytokines during external beam radiation therapy for prostate cancer: a prospective study. Radiother Oncol. 2016;118(1):105–111. doi:10.1016/j.radonc.2015.12.015.
   PubMed Web of Science ®Google Scholar
• Hickok JT, Morrow GR, Roscoe JA, et al. Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage. 2005;30(5):433–442. doi:10.1016/j.jpainsymman.2005.04.012.
   PubMed Web of Science ®Google Scholar
• Berger AM, Mitchell SA. Modifying cancer-related fatigue by optimizing sleep quality. J Natl Compr Canc Netw. 2008;6(1):3–13.
   PubMedGoogle Scholar
• Pinto BM, Dunsiger S, Waldemore M. Physical activity and psychosocial benefits among breast cancer patients. Psycho-Oncol. 2013;22(10):2193–2199.
   Google Scholar
• Langston, B., Armes, J., Levy A, et al. The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature. Supportive Care in Cancer. 2013;21(6):1761–1771.
   PubMed Web of Science ®Google Scholar
• Hsiao C-P, Wang D, Kaushal A, et al. Mitochondria-related gene expression changes are associated with fatigue in patients with nonmetastatic prostate cancer receiving external beam radiation therapy. Cancer Nurs. 2013;36(3):189–197. doi:10.1097/NCC.0b013e318263f514.
   PubMed Web of Science ®Google Scholar
• Danjoux C, Gardner S, Fitch M. Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer. Support Care Cancer. 2007;15(10):1169–1176. doi:10.1007/s00520-007-0229-8.
   PubMed Web of Science ®Google Scholar
• Dhruva AMD, Dodd M, Paul SM, et al. Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy. Cancer Nursing May/June. 2010;33(3):201–212. doi:10.1097/NCC.0b013e3181c75f2a.
   PubMed Web of Science ®Google Scholar
• Hsiao C-P, Wang D, Kaushal A, et al. Differential expression of genes related to mitochondrial biogenesis and bioenergetics in fatigued prostate cancer men receiving external beam radiation therapy. J Pain Symptom Manage. 2014;48(6):1080–1090. doi:10.1016/j.jpainsymman.2014.03.010.
   PubMed Web of Science ®Google Scholar
• Eghbal MA, Pennefather PS, O’Brien PJ. H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation. Toxicology. 2004;203(1–3):69–76. doi:10.1016/j.tox.2004.05.020.
   PubMed Web of Science ®Google Scholar
• Schaue D, McBride WH. T lymphocytes and normal tissue responses to radiation. Front Oncol. 2012;2:119. doi:10.3389/fonc.2012.00119.
   PubMedGoogle Scholar
• Bower JE, Ganz PA, Tao ML, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res. 2009;15(17):5534–5540. doi:10.1158/1078-0432.CCR-08-2584.
   PubMed Web of Science ®Google Scholar
• Ryan JL, Carroll JK, Ryan EP, et al. Mechanisms of cancer-related fatigue. Oncologist. 2007;12 Suppl 1(suppl_1):22–34. doi:10.1634/theoncologist.12-S1-22.
   PubMed Web of Science ®Google Scholar
• Courtier N, Gambling T, Enright S, et al. Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Support Care Cancer. 2013;21(1):173–181. doi:10.1007/s00520-012-1508-6.
   PubMed Web of Science ®Google Scholar
• Wang XS, Shi Q, Williams LA, et al. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun. 2010;24(6):968–974. doi:10.1016/j.bbi.2010.03.009.
   PubMed Web of Science ®Google Scholar
• Wang XS, Williams LA, Krishnan S, et al. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun. 2012;26(5):699–705. doi:10.1016/j.bbi.2011.12.007.
   PubMed Web of Science ®Google Scholar
• Miaskowski C, Dodd M, Lee K, et al. Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. J Pain Symptom Manage. 2010;40(4):531–544. doi:10.1016/j.jpainsymman.2009.12.006.
   PubMed Web of Science ®Google Scholar
• Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci. 1995;57(11):1011–1026.
   PubMed Web of Science ®Google Scholar
• Dantzer R, Bluthé RM, Layé S, et al. Cytokines and sickness behavior. Ann N Y Acad Sci. 1998;840:586–590.
   PubMed Web of Science ®Google Scholar
• Saligan LN, Olson K, Filler K, et al. The biology of cancer-related fatigue: a review of the literature. Support Care Cancer. 2015;23(8):2461–2478. doi:10.1007/s00520-015-2763-0.
   PubMed Web of Science ®Google Scholar
• Saligan LN, Hsiao CP, Wang D, et al. Upregulation of alpha-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways. Brain Behav Immun. 2013;27(1):63–70. doi:10.1016/j.bbi.2012.09.009.
   PubMed Web of Science ®Google Scholar
• Saligan LN, Lukkahatai N, Holder G, et al. Lower brain-derived neurotrophic factor levels associated with worsening fatigue in prostate cancer patients during repeated stress from radiation therapy. World J Biol Psychiatry. 2015;1–7. doi:10.3109/15622975.2015.1012227.
   PubMed Web of Science ®Google Scholar
• Hsiao C-P, Araneta M, Wang XM, et al. The association of IFI27 expression and fatigue intensification during localized radiation therapy: implication of a para-inflammatory bystander response. Int J Mol Sci. 2013;14(8):16943–16957. doi:10.3390/ijms140816943.
   PubMed Web of Science ®Google Scholar
• Hsiao C-P, Reddy SY, Chen M-K, et al. Genomic profile of fatigued men receiving localized radiation therapy. Biol Res Nurs. 2016;18(3):281–289. doi:10.1177/1099800415618786.
   PubMed Web of Science ®Google Scholar
• Pettet AG, Flinton DM. Radiotherapy related fatigue: strategies and knowledge of the UK radiographer and nurse. Radiography. 2002;8:149–158. doi:10.1053/radi.2002.0371.
   Google Scholar
• Grellier N, Deray G, Yousfi A, et al. [Functional iron deficiency, inflammation and fatigue after radiotherapy]. Bull Cancer. 2015;102(9):780–785. French. doi:10.1016/j.bulcan.2015.06.001
   PubMed Web of Science ®Google Scholar
• Mock V, Olsen M. Current management of fatigue and anemia in patients with cancer. Semin Oncol Nurs. 2003;19(4 Suppl 2):36–41.
   PubMedGoogle Scholar
• Feng L, Chen M-K, Lukkahatai N, et al. Clinical predictors of fatigue in men with non-metastatic prostate cancer receiving external beam radiation therapy. Clin J Oncol Nurs. 2015;19(6):744–750. doi:10.1188/15.CJON.744-750.
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Robinson M, Slevin N, et al. Effect of epoetin alfa on survival and cancer treatment–related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer. J Clin Oncol. 2009;27(34):5751–5756. doi:10.1200/JCO.2009.22.3693.
   PubMed Web of Science ®Google Scholar
• Wratten C, Kilmurray J, Nash S, et al. Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys. 2004;59(1):160–167. doi:10.1016/j.ijrobp.2003.10.008.
   PubMed Web of Science ®Google Scholar
• Lind M, Vernon C, Cruickshank D, et al. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer. 2002;86(8):1243–1249. doi:10.1038/sj.bjc.6600247.
   PubMed Web of Science ®Google Scholar
• Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol. 2007;83(1):84–92. doi:10.1016/j.yexmp.2006.09.008.
   PubMed Web of Science ®Google Scholar
• Zhao W, Robbins ME. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem. 2009;16(2):130–143.
   PubMed Web of Science ®Google Scholar
• Nicolson GL, Conklin KA. Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy. Clin Exp Metastasis. 2008;25(2):161–169. doi:10.1007/s10585-007-9129-z.
   PubMed Web of Science ®Google Scholar
• Zabbarova I, Kanai A. Targeted delivery of radioprotective agents to mitochondria. Mol Interv. 2008;8(6):294–302. doi:10.1124/mi.8.6.7.
   PubMedGoogle Scholar
• Mandelker L. Introduction to oxidative stress and mitochondrial dysfunction. Vet Clin North Am Small Anim Pract. 2008;38(1):1–30. doi:10.1016/j.cvsm.2007.10.005.
   PubMed Web of Science ®Google Scholar
• Borisov VB, Liebl U, Rappaport F, et al. Interactions between heme d and heme b595 in quinol oxidase bd from Escherichia coli: a photoselection study using femtosecond spectroscopy. Biochemistry. 2002;41(5):1654–1662.
   PubMed Web of Science ®Google Scholar
• Hinson JT, Fantin VR, Schönberger J, et al. Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome. New England J Med. 2007;356(8):809–819. doi:10.1056/NEJMoa055262.
   PubMed Web of Science ®Google Scholar
• Lesnefsky EJ, Hoppel CL. Oxidative phosphorylation and aging. Ageing Res Rev. 2006;5(4):402–433. doi:10.1016/j.arr.2006.04.001.
   PubMed Web of Science ®Google Scholar
• Kotarsky H, Keller M, Davoudi M, et al. Metabolite profiles reveal energy failure and impaired beta-oxidation in liver of mice with complex III deficiency due to a BCS1L mutation. PLoS One. 2012;7(7):e41156. doi:10.1371/journal.pone.0041156.
   Google Scholar
• Morán M, Marín-Buera L, Gil-Borlado MC, et al. Cellular pathophysiological consequences of BCS1L mutations in mitochondrial complex III enzyme deficiency. Hum Mutat. 2010;31(8):930–941. doi:10.1002/humu.21294.
   PubMed Web of Science ®Google Scholar
• Lill, R., Diekert K, Kaut A, et al. The essential role of mitochondria in the biogenesis of cellular iron-sulfur proteins. Biol Chem. 1999;380(10):1157–1166.
   Web of Science ®Google Scholar
• Hsiao CP, Daly B, Hoppel C. Association between mitochondrial bioenergetics and radiation-related fatigue: a possible mechanism and novel target iMedPub journals. Arch Cancer Res. 2015;3(4):1–9.
   Google Scholar
• National Comprehensive Cancer Network. Cancer-related fatigue. Natl Compr Cancer Netw Pract Guidel Oncol. 2016;1:1–56.
   Google Scholar
• Bruera E, Valero V, Driver L, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2006;24(13):2073–2078. doi:10.1200/JCO.2005.02.8506.
   PubMed Web of Science ®Google Scholar
• Page BR, Shaw EG, Lu L, et al. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol. 2015;17(10):1393–1401. doi:10.1093/neuonc/nov084.
   PubMed Web of Science ®Google Scholar
• Lee EQ, Muzikansky A, Drappatz J, et al. A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy. Neuro Oncol. 2016;18(6):849–854. doi:10.1093/neuonc/now007.
   PubMed Web of Science ®Google Scholar
• Rahmani S, Talepasand S. The effect of group mindfulness - based stress reduction program and conscious yoga on the fatigue severity and global and specific life quality in women with breast cancer. Med J Islam Repub Iran. 2015;29:175–175.
   PubMedGoogle Scholar
• Armes J, Chalder T, Addington-Hall J, et al. A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue. Cancer. 2007;110(6):1385–1395. doi:10.1002/cncr.22923.
   PubMed Web of Science ®Google Scholar
• Potthoff K, Schmidt ME, Wiskemann J, et al. Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study. BMC Cancer. 2013;13(1):162. doi:10.1186/1471-2407-13-162.
   PubMed Web of Science ®Google Scholar
• Bardy J, Finnegan-John J, Molassiotis A, et al. Providing acupuncture in a breast cancer and fatigue trial: the therapists’ experience. Complement Ther Clin Pract. 2015;21(4):217–222. doi:10.1016/j.ctcp.2015.08.003.
   PubMed Web of Science ®Google Scholar
• Zick SM, Alrawi S, Merel G, et al. Relaxation acupressure reduces persistent cancer-related fatigue. Evid Based Complement Alternat Med. 2011. doi:10.1155/2011/142913.
   PubMed Web of Science ®Google Scholar
• Zick SM, Wyatt G, Murphy S, et al. Acupressure for persistent cancer-related fatigue in breast cancer survivors (AcuCrft): a study protocol for a randomized controlled trial. BMC Complement Altern Med. 2012;12:132. doi:10.1186/1472-6882-12-132.
   PubMed Web of Science ®Google Scholar
• Yang L, Li -T-T, Chu Y-T, et al. Traditional Chinese medical comprehensive therapy for cancer-related fatigue. Chin J Integr Med. 2015;22(1):67–72. doi:10.1007/s11655-015-2105-6.
   PubMed Web of Science ®Google Scholar
• Barsevick AM, Dudley W, Beck S, et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004;100(6):1302–1310. doi:10.1002/cncr.20111.
   PubMed Web of Science ®Google Scholar
• Schmidt ME, Meynköhn A, Habermann N, et al. Resistance exercise and inflammation in breast cancer patients undergoing adjuvant radiation therapy: mediation analysis from a randomized, controlled intervention trial. Int J Radiat Oncol Biol Phys. 2016;94(2):329–337. doi:10.1016/j.ijrobp.2015.10.058.
   PubMed Web of Science ®Google Scholar
• Al-Majid S, Wilson LD, Rakovski C, et al. Effects of exercise on biobehavioral outcomes of fatigue during cancer treatment: results of a feasibility study. Biol Res Nurs. 2015;17(1):40–48. doi:10.1177/1099800414523489.
   PubMed Web of Science ®Google Scholar
• Rogers LQ, Anton PM, Fogleman A, et al. Pilot, randomized trial of resistance exercise during radiation therapy for head and neck cancer. Head Neck. 2013;35(8):1178–1188. doi:10.1002/hed.23118.
   PubMed Web of Science ®Google Scholar
• Rogers LQ, Fogleman A, Trammell R, et al. Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial. Integr Cancer Ther. 2013;12(4):323–335. doi:10.1177/1534735412449687.
   PubMed Web of Science ®Google Scholar
• Capozzi LC, McNeely ML, Lau HY, et al. Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: results from an exploratory randomized controlled exercise trial. Cancer. 2016. doi:10.1002/cncr.v122.8.
   PubMed Web of Science ®Google Scholar
• Grabenbauer A, Grabenbauer AJ, Lengenfelder R, et al. Feasibility of a 12-month-exercise intervention during and after radiation and chemotherapy in cancer patients: impact on quality of life, peak oxygen consumption, and body composition. Radiat Oncol. 2016;11(1):42. doi:10.1186/s13014-016-0619-5.
   PubMed Web of Science ®Google Scholar
• Reis D, Walsh ME, Young-McCaughan S, et al. Effects of Nia exercise in women receiving radiation therapy for breast cancer. Oncol Nurs Forum. 2013;40(5):E374–E381. doi:10.1188/13.ONF.E374-E381.
   PubMedGoogle Scholar
• Nicolson GL, Ash ME. Lipid replacement therapy: a natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function. Biochim Biophys Acta. 2014;1838(6):1657–1679. doi:10.1016/j.bbamem.2013.11.010.
   PubMed Web of Science ®Google Scholar
• Nicolson GL. Lipid replacement therapy: a nutraceutical approach for reducing cancer-associated fatigue and the adverse effects of cancer therapy while restoring mitochondrial function. Cancer Metastasis Rev. 2010;29(3):543–552. doi:10.1007/s10555-010-9245-0.
   PubMed Web of Science ®Google Scholar
• Iwase S, Kawaguchi T, Yotsumoto D, et al. Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01). Support Care Cancer. 2016;24(2):637–646. doi:10.1007/s00520-015-2824-4.
   PubMed Web of Science ®Google Scholar
• Stubbe CE, Valero M. Complementary strategies for the management of radiation therapy side effects. J Adv Pract Oncol. 2013;4(4):219–231.
   PubMedGoogle Scholar
• Mustian KM, Morrow GR, Carroll JK, et al. Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist. 2007;12(Suppl 1):52–67. doi:10.1634/theoncologist.12-S1-52.
   PubMed Web of Science ®Google Scholar
• Graziano F, Bisonni R, Catalano V, et al. Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. Br J Cancer. 2002;86(12):1854–1857. doi:10.1038/sj.bjc.6600413.
   PubMed Web of Science ®Google Scholar
• Filler K, Saligan LN. Defining cancer-related fatigue for biomarker discovery. Supportive Care in Cancer. 2015;24(1):5–7. doi:10.1007/s00520-015-2965-5.
   PubMed Web of Science ®Google Scholar
• O’Gorman C, Sasiadek W, Denieffe S, et al. Predicting radiotherapy-related Clinical toxicities in cancer: a literature review. Clin J Oncol Nurs. 2014;18(3):E37–44.
   PubMedGoogle Scholar
• Appling SE, Scarvalone S, MacDonald R, et al. Fatigue in breast cancer survivors: the impact of a mind-body medicine intervention. Oncol Nurs Forum. 2012;39(3):278–286. doi:10.1188/12.ONF.278-286.
   PubMed Web of Science ®Google Scholar